← Back to headlines
Biogen's High-Dose Spinraza Regimen Approved by FDA
Biogen has received approval from the U.S. Food and Drug Administration for its high-dose Spinraza regimen, a treatment for spinal muscular atrophy.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
